The Controlled Substances Board is created in
Wis. Stat. § 15.405(5g) and has authority as outlined in
Wis. Stat. ch. 961.
Members
The members of the Controlled Substances Board are appointed as outlined in
Wis. Stat. § 15.405(5g). The Board consists of seven members with no term expiration dates: the Attorney General, the Secretary of Health Services, and the Secretary of Agriculture, Trade and Consumer Protection, or their designees; the chairperson of the Pharmacy Examining Board, the chairperson of the Medical Examining Board, the chairperson of the Dentistry Examining Board, and the chairperson of the Board of Nursing, or a designee; and two members appointed by the Governor to serve 3-year terms: one psychiatrist member and one pharmacologist member.
| Member | Officer | Member Type | Term Expiration |
|---|
Englebert, Doug
| Chairperson | DHS Designated Member | N/A |
Bloom, Alan
| Vice Chairperson | Pharmacologist | 5/1/2020*
|
| Bellay, Yvonne M. | Secretary | DATCP Designated Member | N/A |
Alton, Troy A.
|
| Dentistry Board Representative
| N/A
|
| Barman, Subhadeep |
| Psychiatrist
| 5/1/2019*
|
Bistan, Matthew R.
|
| Dentistry Board Alternate Representative
| N/A
|
Eberhardy, Cullen M.
|
| Attorney General Designee
| N/A
|
Ferguson, Kris
|
| Medical Board Alternate Representative
| N/A
|
Kane, Amanda K.
|
| Board of Nursing Representative
| N/A
|
Schmeling, Gregory
|
| Medical Board Representative
| N/A |
Weinman. Robert W.
|
| Board of Nursing Alternate Representative
| N/A
|
Weitekamp, John G.
| | Pharmacy Board Representative | N/A |
*Board members whose terms have expired may continue to serve until their successor is appointed.
Announcements
On April 1, 2017, an emergency rule amending
ch. CSB 4 went into effect. This emergency rule revises requirements for the Prescription Drug Monitoring Program.
2013 Wisconsin Act 267, also known as Lydia's Law, charges the Controlled Substances Board with aiding a physician in applying for and processing an investigational drug permit for use of cannabidoil (CBD oil) as treatment for a seizure disorder.
Investigational Drug Permit For Cannabidoil
Last updated: 11/8/2023